In an experimental model in which sufficient residual CFTR function is maintained and animals have not developed exocrine pancreatic insufficiency, the underlying mechanisms appear to involve duct cells and the immune system, whereas acinar cells are not the source but a target of the CFTR pancreas phenotype. This evidence concerns the gene CFTR and exocrine pancreatic insufficiency.